Condensed Consolidated Statements of Cash Flows $ in Millions	3 Months Ended	6 Months Ended
	Jun. 28, 2024 USD ($)	Jun. 28, 2024 USD ($)	Jun. 30, 2023 USD ($)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents		$ (2.2)	$ (1.1)
Net loss	$ (43.3)
Depreciation and amortization		67.2	286.2
Deferred income taxes		16.3	475.5
(Amortization) accretion expense on debt premium/discount and settlement obligation		(2.1)	138.6
Other Noncash Income (Expense)		(5.8)	(16.8)
Increase (Decrease) in Accounts Receivable		18.6	(14.4)
Increase (Decrease) in Inventories		(161.6)	(75.7)
Accounts payable		(11.5)	(24.5)
Income taxes		(5.9)	159.4
Increase (Decrease) in Other Operating Assets and Liabilities, Net		41.0	12.8
Net Cash Provided by (Used in) Operating Activities		47.0	121.0
Payments to Acquire Property, Plant, and Equipment		50.9	26.3
Payments for (Proceeds from) Other Investing Activities		(0.7)	(0.7)
Net Cash Provided by (Used in) Investing Activities		(27.6)	(25.6)
Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security		4.4	22.0
Net Cash Provided by (Used in) Financing Activities		(4.6)	(22.1)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect		12.6	72.2
Cash and cash equivalents	291.1	291.1	480.6
Restricted Cash and Investments, Current	23.6	23.6	22.7
Restricted Cash and Investments, Noncurrent	41.3	41.3	35.6
Cash Flows From Operating Activities:
Net loss	(43.3)
Adjustments to reconcile net cash from operating activities:
Depreciation and amortization		67.2	286.2
Deferred income taxes		16.3	475.5
Other non-cash items		5.8	16.8
Changes in assets and liabilities:
Accounts receivable, net		(18.6)	14.4
Inventories		161.6	75.7
Accounts payable		(11.5)	(24.5)
Income taxes		(5.9)	159.4
Other		(41.0)	(12.8)
Net Cash From Operating Activities		47.0	121.0
Cash Flows From Investing Activities:
Capital expenditures		(50.9)	(26.3)
Other		0.7	0.7
Net Cash From Investing Activities		(27.6)	(25.6)
Cash Flows From Financing Activities:
Repayment of debt		(4.4)	(22.0)
Net Cash Provided From Financing Activities		(4.6)	(22.1)
Net change in cash, cash equivalents and restricted cash		12.6	72.2
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	356.0	356.0	538.9
Cash and cash equivalents, end of period	291.1	291.1	480.6
Proceeds from Sale of Restricted Investments		22.6	0.0
Acthar Gel-Related Litigation Settlement liability		(21.4)	(16.5)
Repurchase of shares		0.0	(0.1)
Other		(0.2)
Retained Earnings (Deficit)
Net loss	(43.3)	(108.7)	(997.1)
Cash Flows From Operating Activities:
Net loss	(43.3)	(108.7)	(997.1)
Additional Paid-In Capital
Share-based compensation	3.4	5.3	5.3
Adjustments to reconcile net cash from operating activities:
Share-based compensation	$ 3.4	$ 5.3	$ 5.3